4 completed, 2 unknown, 1 terminated, 1 withdrawn. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 4, Unknown 2, Terminated 1, Withdrawn 1 |
Follow Antirheumatic Agents: new trials by email Literature Review of Antirheumatic Agents trials Research Report on Antirheumatic Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunosuppressant Combined With Pirfenidone in CTD-ILD Pirfenidone, DMARDs - Pirfenidone, Connective Tissue Diseases | Phase 4 | Unknown | Qilu Hospital of Shandong University | 200 | 2019-08-16 | 2023-11-18 |
| Rheumatoid Arthritis Memory B Cells and Abatacept Abatacept, DMARDs - Rheumatoid Arthritis | Phase 4 | Completed | NYU Langone Health | 25 | 2019-06-02 | 2024-07-03 |
| Optimal MTX Dose With Folic Acid Randomized Case-control Trial MTX, Folic Acid, DMARDs - Rheumatoid Arthritis | Phase 4 | Unknown | Sun Yat-sen University | 160 | 2018-08-01 | 2019-08-26 |
| A Long-term Safety Extension Study of Tocilizumab in Brazilian Participants With Rheumatoid Arthritis (RA) Who Completed the Studies ML21530 and MA21488 DMARDs, Tocilizumab - Arthritis, Rheumatoid | Phase 4 | Completed | Hoffmann-La Roche | 26 | 2013-01-15 | 2017-06-12 |
| A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis tocilizumab [RoActemra/Actemra], DMARD - Rheumatoid Arthritis | Phase 4 | Terminated | Hoffmann-La Roche | 2 | 2011-11-01 | 2014-11-11 |
| RHYTHM (Formerly Escape II Myocardium) TNF inhibitors, DMARDs - Rheumatoid Arthritis | Phase 4 | Completed | Columbia University | 149 | 2011-10-10 | 2020-11-27 |
| A Study of Tocilizumab Added to DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to DMARDs. tocilizumab [RoActemra/Actemra], DMARDs (disease-modifying antirheumatic drugs) - Rheumatoid Arthritis | Phase 4 | Completed | Hoffmann-La Roche | 201 | 2009-10-31 | 2018-03-29 |
| A Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Treatment of Rheumatoid Arthritis Etanercept + Methotrexate, DMARDS - Rheumatoid Arthritis | Phase 4 | Withdrawn | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-11-01 | 2022-05-09 |
Arthritis, Rheumatoid (8) · Cardiovascular Diseases (1) · Connective Tissue Diseases (1) · Lung Diseases, Interstitial (1) · Myositis (1) · Scleroderma, Systemic (1)
Hoffmann-La Roche (3) · Columbia University (1) · NYU Langone Health (1) · Qilu Hospital of Shandong University (1) · Sun Yat-sen University (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
China (2) · United States (2) · Brazil (1) · Finland (1) · Russia (1)
Gregg Silverman, MD (1) · Joan M Bathon, MD (1) · William Rigby, MD (1) · Yang Xiaoyun, Dr. (1) · Yun Feng Pan, Master (1)
R01AR050026 (1)